Harmony Biosciences Holdings
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +5.1% | -8.2% | +11.8% | +7.7% | +8.2% | -8.2% | +8.5% | +19.4% | +1.8% | -11.6% | +21.3% | – | |
| – | +33.6% | -36.3% | +17.0% | +33.1% | +27.2% | -41.2% | +19.3% | +56.3% | +14.9% | -35.1% | +42.0% | – | |
| – | -2.1% | +1.5% | +10.6% | +1.8% | +2.5% | +4.0% | +6.3% | +10.8% | -2.5% | -2.5% | +15.9% | – | |
| – | +73.2% | -26.8% | +186.6% | -60.1% | +36.6% | -0.4% | +45.2% | +9.6% | -9.1% | +39.0% | -32.8% | – | |
| – | +23.6% | -7.9% | +6.0% | +5.0% | +1.0% | +8.2% | +8.6% | -12.1% | +93.1% | -43.5% | -13.7% | – | |
| – | +34.0% | -11.7% | +58.9% | -31.7% | +11.7% | +5.9% | +18.3% | +0.1% | +19.6% | -2.3% | -18.6% | – | |
| – | -37.7% | +29.4% | -59.0% | +189.0% | -9.7% | +0.9% | -14.3% | +35.9% | -41.1% | -3.3% | +139.5% | – | |
| – | -31.6% | -5.4% | -2.9% | -1.3% | -3.2% | -8.9% | -5.0% | -0.7% | -2.1% | -8.8% | -4.8% | – | |
| – | -23.4% | +30.5% | -58.1% | +186.6% | -9.7% | +1.8% | -13.2% | +36.0% | -39.6% | -2.6% | +135.0% | – | |
| – | -2.2% | +2.8% | -24.9% | +59.1% | -58.4% | +73.9% | -15.1% | +68.6% | +9.9% | -60.6% | +147.7% | – | |
| – | -30.8% | +44.1% | -69.8% | +297.7% | +7.3% | -7.9% | -12.7% | +27.9% | -55.8% | +44.5% | +132.2% | – | |
| – | -5.7% | +2.0% | -48.5% | +125.5% | -8.5% | +1.0% | -11.5% | +24.0% | -29.6% | -5.5% | +109.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.